Calendar Nxera Pharma Co., Ltd.

Equities

4565

JP3431300007

Market Closed - Japan Exchange 02:00:00 2024-07-18 am EDT 5-day change 1st Jan Change
1,634 JPY -2.16% Intraday chart for Nxera Pharma Co., Ltd. -1.27% +14.99%

Chart calendar Nxera Pharma Co., Ltd.

e438fc3a28b554822de2eee3b8d6b45a.30gAuKfTaeBxQtX2T6spXAHJVxqqe9gYDghywcxolpI.sA0z9uaFB5IfF4qsJM9bCmz9MlXzIbd_NnIYqqEM_9_pIWLu3ZtRpxU07Q~6a0bf2ac45bc7176fd85a295340bbaa7

Upcoming events on Nxera Pharma Co., Ltd.

2024-08-08 Q2 2024 Earnings Release
2024-08-09 03:30 am Q2 2024 Earnings Call
2024-11-10 Q3 2024 Earnings Release
2025-02-17 Q4 2024 Earnings Release (Projected)
2025-05-08 Q1 2025 Earnings Release (Projected)
2025-08-06 Q2 2025 Earnings Release (Projected)
2025-11-17 Q3 2025 Earnings Release (Projected)

Past events on Nxera Pharma Co., Ltd.

2024-05-09 02:30 am Q1 2024 Earnings Release
2024-03-26 09:00 pm Annual General Meeting
2024-02-13 03:00 am Q4 2023 Earnings Call
2024-02-13 01:30 am Q4 2023 Earnings Release
2024-01-10 04:30 pm JPMorgan Healthcare Conference
2023-11-14 05:30 am Jefferies London Healthcare Conference
2023-11-11 04:30 pm J.P. Morgan Healthcare Conference
2023-11-10 02:07 am Q3 2023 Earnings Release
2023-11-10 02:00 am R&D Day
2023-08-04 04:00 am Q2 2023 Earnings Call
2023-08-03 Q2 2023 Earnings Release
2023-07-20 04:00 am Acquisition of Idorsia Pharmaceutical Ltd By Sosei Group Corp Call
2023-05-12 02:30 am Q1 2023 Earnings Release
2023-03-22 09:00 pm Annual General Meeting
2023-02-14 03:00 am FY 2022 Earnings Call
2023-02-14 01:30 am FY 2022 Earnings Release
2023-01-11 04:30 pm J.P. Morgan Healthcare Conference
2022-11-15 06:30 am Jefferies London Healthcare Conference
2022-11-11 01:44 am Q3 2022 Earnings Release
2022-10-13 02:30 am R&D Day

Past dividends on Nxera Pharma Co., Ltd.

2015-03-26 Bonus Payment 10 JPY

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million JPY
Released
Forecast
Spread
9 726
8 894
9.36%
8 842
9 821
-9.97%
17 712
16 418
7.88%
15 569
15 096
3.13%
12 766
16 328
-21.81%

37 284

EBITDA
Million JPY
Released
Forecast
Spread
1 873
4 930
-62.01%
2 278
2 389
-4.66%
5 053
7 040
-28.22%
4 781
1 629
193.55%
-7 048
-5 290
-33.23%

4 576

EBIT
Million JPY
Released
Forecast
Spread
384
1 851
-79.25%
928
1 395
-33.48%
3 775
6 308
-40.15%
3 436
2 635
30.41%
-9 526
-5 364
-77.59%

3 348

Earnings before Tax (EBT)
Million JPY
Released
Forecast
Spread
534
4 704
-88.65%
1 622
2 398
-32.36%
433
6 887
-93.71%
1 078
1 975
-45.41%
-10 680
-7 618
-40.2%

3 652

Net income
Million JPY
Released
Forecast
Spread
1 432
2 419
-40.81%
1 479
1 244
18.85%
475
5 519
-91.39%
382
1 854
-79.4%
-7 913
-2 898
-173.08%

1 377

EPS
JPY
Released
Forecast
Spread
18,7
34,9
-46.36%
18,8
11,8
59.64%
5,86
68,6
-91.46%
4,68
22,7
-79.43%
-87,2
-75,5
-15.47%

31,6

Announcement Date13/02/2012/02/2110/02/2214/02/2313/02/24-

Quarterly results

Fiscal PeriodDecember 2019 S2 2020 S1 2021 S1 2021 S2 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million JPY
Released
Forecast
Spread
4 670
10 204
-54.23%
2 516


3 123
3 155
-1.01%
14 589
13 107
11.31%
1 119
1 060
5.57%
1 338
1 220
9.67%
2 457


6 184
5 400
14.52%
6 928
5 399
28.32%
13 112
11 583
13.2%
943


2 146


3 328
7 000
-52.46%
7 292
13 254
-44.98%
4 611
11 300
-59.19%

8 500


16 600


14 589

EBITDA
Million JPY
Released
Forecast
Spread










































-2 093



1 520


3 620


136

EBIT
Million JPY
Released
Forecast
Spread
-347
5 461
-106.35%
-1 136


-1 849
-996
-85.64%
5 624
6 539
-13.99%
-2 206
-1 640
-34.51%



-3 804


3 189


4 051
1 565
158.85%
7 240
4 754
52.29%
-1 964


-4 168


-3 554
3 390
-204.84%
-1 534
5 148
-129.8%
-3 076
2 300
-233.74%

1 520


3 620


136

Earnings before Tax (EBT)
Million JPY
Released
Forecast
Spread
242
5 600
-95.68%
-1 270


-1 393
-996
-39.86%
1 826
7 030
-74.03%
-2 497
-1 640
-52.26%



-4 282


1 174


4 186
2 122
97.27%
5 360
3 296
62.62%
-1 863


-3 760


-4 105
3 490
-217.62%
-2 815
1 619
-273.87%
-2 796
2 250
-224.27%

1 470


3 570


-244

Net income
Million JPY
Released
Forecast
Spread
1 037
4 700
-77.94%
-2 117


-2 297
-996
-130.62%
2 772
7 100
-60.96%
-2 070
-1 691
-22.41%



-3 538


313


3 607
2 925
23.32%
3 920
3 238
21.06%
-1 402


-2 060


-4 925
2 490
-297.79%
-928
1 070
-186.73%
-3 281
2 950
-211.22%

1 170


2 970


741

EPS
JPY
Released
Forecast
Spread



-27,5


-28,4





-25,4





-43,3


3,87








-17,1


-25,1


-59,9
30,7
-295.37%
-2,13
13,2
-116.16%
-36,7
18,9
-294.54%

-67,3


-73,3


108

Announcement Date13/02/2013/08/2012/08/2110/02/2213/05/2210/08/2210/08/2211/11/2214/02/2314/02/2312/05/2304/08/2310/11/2313/02/2409/05/24---

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 4565 Stock
  4. Calendar Nxera Pharma Co., Ltd.